Xylo Technologies Ltd (XYLO) AI Stock Analysis

• Market Cap: $4.08M
• Dividend Yield: N/A
• Average Volume (3M): 5.82K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.44
• Revenue Growth: -67.73%
• EPS Growth: 66.23%
• Country: US
• Employees: 38
• Sector: Healthcare
• Sector Strength: 37
• Industry: Medical - Devices
• EPS (TTM): 2.66
• Shares Outstanding: 1,281,042
• 10 Day Avg. Volume: 4,329
• 30 Day Avg. Volume: 5,818
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: -1.00
• Enterprise Value/Revenue: -0.07
• Enterprise Value/Gross Profit: -0.52
• Enterprise Value/Ebitda: 0.78
• 1Y Price Target: $5.00
• Price Target Upside: -1.19% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 46 Neutral
• Price Target: $5.00 ▼(-1.19% Downside)

Xylo Technologies Ltd faces significant financial challenges, with consistent losses and negative cash flows being the most impactful factors. The technical analysis provides mixed signals, indicating a lack of clear market direction. The valuation is concerning due to a negative P/E ratio and no dividend yield, further impacting the overall score.

Xylo Technologies Ltd Business Overview & Revenue Model

Company Description

Xylo Technologies Ltd (XYLO) is a forward-thinking technology company specializing in innovative software solutions and digital transformation services. Operating primarily in the information technology sector, XYLO focuses on developing cutting-edge applications that enhance business operations and customer engagement across various industries, including healthcare, finance, and retail. The company is committed to leveraging advanced technologies such as artificial intelligence, machine learning, and cloud computing to deliver scalable and efficient products that meet the evolving needs of its clientele.

How the Company Makes Money

Xylo Technologies Ltd generates revenue through a diversified model that includes software licensing, subscription fees for its SaaS (Software as a Service) offerings, and consulting services. Key revenue streams include the sale of proprietary software solutions tailored to specific industries, which are often offered under a licensing agreement. Additionally, the company earns recurring revenue from subscription-based services that provide ongoing access to its cloud-based applications. XYLO also engages in strategic partnerships with other tech firms and industry leaders to enhance its product offerings and expand market reach, further contributing to its earnings through co-developed solutions and joint marketing initiatives.

Xylo Technologies Ltd Financial Statement Overview

Summary

Xylo Technologies Ltd faces financial challenges with declining revenues, negative EBIT and net income margins, and liquidity issues. While a positive equity ratio is maintained, high leverage and inability to generate positive cash flows present ongoing risks.

Income Statement

Xylo Technologies Ltd has faced significant challenges in maintaining revenue growth and profitability. The company experienced a notable decline in revenue from 2023 to 2024, with a negative revenue growth rate, and continues to report negative EBIT and net income margins. Despite a consistent gross profit margin, the inability to convert this into positive net income indicates ongoing operational inefficiencies.

Balance Sheet

The company's balance sheet shows a mixed picture. A positive equity ratio reflects a solid capital structure, but the high debt-to-equity ratio indicates potential leverage risks. The declining equity and assets over the years highlight a need for strategic financial management to stabilize the company's financial position.

Cash Flow

Xylo Technologies Ltd has struggled with negative operating and free cash flows, reflecting ongoing liquidity challenges. The company's cash flow from operations remains negative, accentuating the need for improved cash management. However, the reduction in net debt is a positive indicator, suggesting some progress in managing financial obligations.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	29.86M	91.72M	91.86M	10.12M	531.00K
Gross Profit	6.68M	11.84M	14.45M	4.80M	-503.00K
EBITDA	-7.51M	-12.19M	-5.38M	6.99M	-7.30M
Net Income	-6.03M	-16.02M	-9.81M	6.79M	-4.33M
Balance Sheet
Total Assets	37.55M	63.90M	97.65M	59.73M	32.34M
Cash, Cash Equivalents and Short-Term Investments	14.67M	12.54M	25.23M	27.34M	22.36M
Total Debt	6.86M	9.79M	10.13M	1.62M	107.00K
Total Liabilities	19.96M	31.46M	42.96M	8.30M	6.14M
Stockholders Equity	17.98M	23.58M	39.14M	49.19M	22.96M
Cash Flow
Free Cash Flow	-1.84M	-7.99M	-5.73M	-10.39M	-6.47M
Operating Cash Flow	-1.82M	-6.25M	-5.66M	-5.25M	-6.14M
Investing Cash Flow	2.38M	-4.06M	-4.48M	-12.21M	-1.60M
Financing Cash Flow	-998.00K	-524.00K	5.41M	18.92M	22.95M

Xylo Technologies Ltd Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 5.06
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XYLO, the sentiment is Positive. The current price of 5.06 is below the 20-day moving average (MA) of 5.06, above the 50-day MA of 5.04, and above the 200-day MA of 4.52, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 57.64 is Neutral, neither overbought nor oversold. The STOCH value of 47.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XYLO.

Xylo Technologies Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	57 Neutral	£5.20B	5.91	-64.94%	2.22%	32.35%	-8.43%
HSCS	48 Neutral	$7.85M	―	-233.04%	―	-76.61%	73.25%
XYLO	46 Neutral	$4.08M	―	-28.95%	―	-67.73%	66.23%
NUWE	44 Neutral	$591.90K	―	-440.77%	―	-1.21%	93.72%
VERO	43 Neutral	$4.55M	―	-496.27%	―	-16.79%	-3.69%
SINT	42 Neutral	$6.75M	―	-155.20%	―	9.90%	94.56%
RSLS	37 Underperform	$6.16M	―	-120.16%	―	-7.74%	93.25%